# Nebulized Lidocaine vs 3% Sodium Chloride in Pediatric Adenoid/Tonsil Surgery

> **NCT07267897** · NA · NOT_YET_RECRUITING · sponsor: **Sakarya University** · enrollment: 90 (estimated)

## Conditions studied

- Postoperative Respiratory Complication

## Interventions

- **DRUG:** Nebulize Lidocaine
- **DRUG:** Nebulize %3 Sodium Chloride

## Key facts

- **NCT ID:** NCT07267897
- **Lead sponsor:** Sakarya University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2026-06-15
- **Final completion:** 2026-10-15
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07267897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07267897, "Nebulized Lidocaine vs 3% Sodium Chloride in Pediatric Adenoid/Tonsil Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07267897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*